Cargando…

Treatment of hepatocellular carcinoma with recombinant leucocyte interferon: a pilot study.

Detalles Bibliográficos
Autores principales:	Sachs, E., Di Bisceglie, A. M., Dusheiko, G. M., Song, E., Lyons, S. F., Schoub, B. D., Kew, M. C.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1985
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1977152/ https://www.ncbi.nlm.nih.gov/pubmed/2990514

Ejemplares similares

Evaluation of leucocyte adherence inhibition in hepatocellular carcinoma.
por: Dusheiko, G. M., et al.
Publicado: (1979)

Detection of alpha-foetoprotein messenger RNA in human hepatocellular carcinoma and hepatoblastoma tissue.
por: Di Bisceglie, A. M., et al.
Publicado: (1986)

HLA expression in human hepatocellular carcinoma.
por: Paterson, A. C., et al.
Publicado: (1988)

Leucocyte subset-specific type 1 interferon signatures in SLE and other immune-mediated diseases
por: Flint, Shaun M, et al.
Publicado: (2016)

Recombinant alpha 2 interferon is superior to doxorubicin for inoperable hepatocellular carcinoma: a prospective randomised trial.
por: Lai, C. L., et al.
Publicado: (1989)

Induction of interferon synthesis in rainbow trout leucocytes by various homeotherm viruses
por: Snegaroff, J.
Publicado: (1993)

Survival in renal cell carcinoma-a randomized evaluation of tamoxifen vs interleukin 2, alpha-interferon (leucocyte) and tamoxifen.
por: Henriksson, R., et al.
Publicado: (1998)

Aberrant human leucocyte antigen-G expression and its clinical relevance in hepatocellular carcinoma
por: Lin, A, et al.
Publicado: (2010)

Localization of leucocyte interferon gene in the q2.5 region of pig chromosomel by in situ hybridization
por: Yerle, M, et al.
Publicado: (1989)

Survival in renal cell carcinoma: a randomized evaluation of tamoxifen vs interleukin-2, α-interferon (leucocyte) and tamoxifen
Publicado: (2000)

Decreased natural killer cell activity and interferon production by leucocytes in patients with adenocarcinoma of the pancreas.
por: Funa, K., et al.
Publicado: (1984)

Overexpression of leucocyte common antigen (LAR) P-subunit in thyroid carcinomas
por: Konishi, N, et al.
Publicado: (2003)

Leucocyte function
por: Matera, Lina
Publicado: (1983)

LEUCOCYTIC SECRETIONS
por: Carrel, Alexis, et al.
Publicado: (1922)

The Leucocyte in Disease
por: Jones, H. S. Wansbrough
Publicado: (1896)

Survival in renal cell carcinoma: a randomized evaluation of tamoxifen vs interleukin-2, α-interferon (leucocytic) and tamoxifen – reply
Publicado: (2000)

BACTERICIDAL ACTIVITY OF RAT LEUCOCYTIC EXTRACTS : II. CHARACTERIZATION OF THE BACTERICIDAL SUBSTANCE IN LEUCOCYTE MITOCHONDRIAL EXTRACTS
por: Fishman, M., et al.
Publicado: (1957)

Hepatitis Viruses and Human Hepatocellular Carcinoma
por: Kew, Michael C.
Publicado: (1997)

Hepatocellular carcinoma: epidemiology and risk factors
por: Kew, Michael C
Publicado: (2014)

Interactive Effects of Immunoglobulin Gamma and Human Leucocyte Antigen Genotypes on Response to Interferon Based Therapy of Hepatitis C Virus
por: Gomaa, Howayda E., et al.
Publicado: (2015)

The Leucocyte in Health and Disease
Publicado: (1925)

The Differential Leucocyte Count
por: Hefferman, L. W.
Publicado: (1923)

The Leucocyte in Disease.—II
por: Jones, H. Wansbrough
Publicado: (1896)

Value of the Leucocyte Count
Publicado: (1907)

Whither α-FP in the diagnosis of hepatocellular carcinoma?
por: Kew, Michael C
Publicado: (2015)

Evaluation of the effect of continuous infusion recombinant interleukin-2 (bioleukin) on peripheral blood leucocytes of patients with terminal malignancy.
por: Oliver, R. T., et al.
Publicado: (1989)

Patterns of cyclic nucleotides in normal and leukaemic human leucocytes.
por: Peracchi, M., et al.
Publicado: (1980)

Relationship between polymorphonuclear leucocytes and the outcome of patients with severe trauma
por: Eforakopoulou, M, et al.
Publicado: (2006)

Expression of MHC products and leucocyte differentiation antigens in gynaecological neoplasms: an immunohistological analysis of the tumour cells and infiltrating leucocytes.
por: Ferguson, A., et al.
Publicado: (1985)

THE IN VITRO ACTION OF HYDROCORTISONE ON LEUCOCYTE MIGRATION
por: Ketchel, Melvin M., et al.
Publicado: (1958)

Organ-related and malignancy-associated reactivity of cancer patients' leucocytes: a leucocyte migration study with tumour and foetal extracts.
por: Matzku, S., et al.
Publicado: (1980)

Serum zinc levels in hepatocellular carcinoma.
por: Dunn, J. A., et al.
Publicado: (1969)

HCV Genome-Wide Genetic Analyses in Context of Disease Progression and Hepatocellular Carcinoma
por: Donlin, Maureen J., et al.
Publicado: (2014)

Leucocytes: Can They Be Developed Spontaneously in Blastemata? Origin of Leucocytes Found in the Midst of Blastemata Primarily Amorphous, Isolated in Permeable Receptacles
por: Lortet, M.
Publicado: (1868)

Carbohydrate antigen 19-9 as a serum marker of hepatocellular carcinoma: comparison with alpha-foetoprotein.
por: Kew, M. C., et al.
Publicado: (1987)

Immune Responses Following Locoregional Treatment for Hepatocellular Carcinoma: Possible Roles of Adjuvant Immunotherapy
por: Han, Ji-Won, et al.
Publicado: (2021)

In vivo noninvasive microscopy of human leucocytes
por: Winer, Matan M., et al.
Publicado: (2017)

Prognostic Significance of Leucocytic Count in Bubonic Plague
por: Wagle, P. M., et al.
Publicado: (1947)

Leucocyte Membrane Determinants Regulating Immune Reactivity
por: Cone, Robert E.
Publicado: (1978)

A comparison of statistical methods for the detection of hepatocellular carcinoma based on serum biomarkers and clinical variables
por: Wang, Mengjun, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_r2n5i2k0c3f014krksbm50565d